Pediatrix Medical (MD) | Stock Overview & Key Data
Pediatrix Medical Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $86.09 on August 17, 2015
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.91B Small-cap | 8.46% | 8.36% | 25.04% | 7.40% | 14.47% | 73.57% | 75.20% | -20.69% | -64.71% | -31.34% | 9.12% | |
|
HCA Healthcare
HCA
|
106.00B Large-cap | 7.93% | -7.81% | -25.75% | -18.24% | -17.10% | 4.31% | 33.47% | 92.28% | 400.04% | 1,019.34% | 1,144.15% |
|
Tenet Healthcare
THC
|
16.50B Large-cap | 9.88% | -8.92% | -18.33% | -9.23% | -10.20% | 6.26% | 122.70% | 164.92% | 543.08% | 581.20% | 489.27% |
|
Surgery Partners
SGRY
|
1.86B Small-cap | 9.24% | 8.46% | 22.11% | -2.01% | -0.85% | -32.67% | -62.68% | -76.34% | -2.17% | -16.93% | -16.93% |
|
Astrana Health
ASTH
|
1.88B Small-cap | -0.03% | 0.31% | 56.02% | 72.11% | 52.18% | 49.98% | 24.10% | -27.77% | 642.69% | 657.25% | 657.25% |
|
Addus HomeCare
ADUS
|
1.78B Small-cap | 5.83% | 17.82% | 21.42% | 5.38% | 7.45% | -17.30% | 1.60% | 15.52% | 399.36% | 1,747.13% | 919.45% |
Ownership & Short Interest
Calculate Your Pediatrix Medical Investment Returns
Long-Term Investment Performance Analysis
Pediatrix Medical stock price in Jul 2016 was $75.91, A $1,000.00 lump sum investment in Pediatrix Medical made 9 years ago would be worth approximately $321.04 today, representing a negative return of -67.90%. This translates to an annualized return (CAGR) of -10.83%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is MD's 52-week high and low?
- In the last 52 weeks, Pediatrix Medical reached a high of $24.99 (on November 28, 2025) and a low of $11.84 (on August 1, 2025).
- What is the market cap and P/E ratio for MD?
- Curious about Pediatrix Medical's size and valuation? Its market capitalization stands at 1.91B. When it comes to valuation, the P/E ratio (trailing twelve months) is 11.88, and the forward P/E (looking ahead) is 9.90.
- Does MD pay dividends? If so, what's the yield?
- As for dividends, Pediatrix Medical isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Pediatrix Medical's main competitors or similar companies to consider before investing?
When looking at Pediatrix Medical, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return HCA Healthcare
HCA106.00B Healthcare Medical Care Facilities 4.31% 33.47% Tenet Healthcare
THC16.50B Healthcare Medical Care Facilities 6.26% 122.70% Surgery Partners
SGRY1.86B Healthcare Medical Care Facilities -32.67% -62.68% Astrana Health
ASTH1.88B Healthcare Medical Care Facilities 49.98% 24.10% Addus HomeCare
ADUS1.78B Healthcare Medical Care Facilities -17.30% 1.60% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Pediatrix Medical Group, Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Pediatrix Medical's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 20.28%, the Debt to Equity ratio from the most recent quarter is 73.29, and its Gross Profit Margin stands at 25.51%.
- What is the recent revenue and earnings growth for MD?
- Looking at Pediatrix Medical's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by -1.70%, and quarterly earnings saw a YoY growth of 10.50%.
- How much of MD stock is held by insiders and institutions?
- Wondering who owns Pediatrix Medical stock? Company insiders (like executives and directors) hold about 2.31% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 106.63%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.